AZN · Categories · Coverage
AZN - Analyst coverage initiated
AstraZeneca PLC (AZN) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for AZN
- Citigroup initiated coverage on AstraZenecaCitigroup initiated coverage of AstraZeneca with a rating of Buy
- Exane BNP Paribas initiated coverage on AstraZeneca with a new price targetExane BNP Paribas initiated coverage of AstraZeneca with a rating of Outperform and set a new price target of $75.00
- Morgan Stanley initiated coverage on AstraZenecaMorgan Stanley initiated coverage of AstraZeneca with a rating of Overweight
- Goldman initiated coverage on AstraZeneca with a new price targetGoldman initiated coverage of AstraZeneca with a rating of Buy and set a new price target of $97.00
- Morgan Stanley initiated coverage on AstraZeneca with a new price targetMorgan Stanley initiated coverage of AstraZeneca with a rating of Overweight and set a new price target of $85.00
- HSBC Securities initiated coverage on AstraZeneca with a new price targetHSBC Securities initiated coverage of AstraZeneca with a rating of Buy and set a new price target of $78.00
- HSBC Securities initiated coverage on AstraZenecaHSBC Securities initiated coverage of AstraZeneca with a rating of Buy
- BMO Capital Markets initiated coverage on AstraZeneca with a new price targetBMO Capital Markets initiated coverage of AstraZeneca with a rating of Outperform and set a new price target of $82.00
- The Goldman Sachs Group initiated coverage on AstraZeneca PLC (AZN.L) with a new price targetThe Goldman Sachs Group initiated coverage of AstraZeneca PLC (AZN.L) with a rating of Sell and set a new price target of $6,575.00
- Barclays initiated coverage on AstraZeneca PLC (AZN.L) with a new price targetBarclays initiated coverage of AstraZeneca PLC (AZN.L) with a rating of Buy and set a new price target of $9,000.00